Rotating inotrope therapy in a pediatric population with decompensated heart failure

Pediatric Critical Care Medicine

Volumn 12, Issue 1, 2011, Pages 57-60

  Ryerson, Lindsay M ^a   Alexander, Peta M A ^a   Butt, Warwick W ^a   Shann, Frank A ^a   Penny, Daniel J ^a   Shekerdemian, Lara S ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

children; congenital heart disease; heart failure; levosimendan

Indexed keywords

DOBUTAMINE; LEVOSIMENDAN; MILRINONE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DECOMPENSATED CONGESTIVE HEART FAILURE; DISEASE COURSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEART ARRHYTHMIA; HEART SURGERY; HEART TRANSPLANTATION; HOSPITAL DISCHARGE; HUMAN; INFANT; INTENSIVE CARE UNIT; LOADING DRUG DOSE; MALE; PEDIATRICS; POSITIVE END EXPIRATORY PRESSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SCHOOL CHILD; TERTIARY HEALTH CARE; UNSPECIFIED SIDE EFFECT;

EID: 78751645065     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181e2a437     Document Type: Article

References (18)

1. Unverferth DV, Blanford M, Kates RE, et al: Tolerance to dobutamine after a 72 hour continuous infusion. Am J Med 1980; 69: 262-266
2. Elis A, Bental T, Kimchi D, et al: Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: A randomized, double-blind, placebo-controlled study. Clin Pharmacol Ther 1998; 63: 682-685
3. Gonzalez G, Rodriguez D: Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: Potential role of levosimendan. Am J Cardiovasc Drugs 2006; 6:69-75
4. Lilleberg J, Laine M, Palkama T, et al: Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure. Eur J Heart Fail 2007; 9:75-82
5. Antila S, Sundberg S, Lehtonen LA: Clinical pharmacology of levosimendan. Clin Phar-macokinet 2007; 46:535-552
6. Nanas JN, Papazoglou P, Terrovitis JV, et al: Hemodynamic effects of levosimendan added to dobutamine in patients with decompen-sated heart failure refractory to dobutamine alone. Am J Cardiol 2004; 94:1329-1332
7. Nanas JN, Papazoglou P, Tsagalou EP, et al: Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosi-mendan infusions in severe heart failure refractory to dobutamine alone. Am J Cardiol 2005; 95:768-771
8. Namachivayam P, Crossland DS, Butt WW, et al: Early experience with levosimendan in children with ventricular dysfunction. Pedi-atr Crit Care Med 2006; 7:445-448
9. Berg AM, Snell L, Mahle WT: Home inotropic therapy in children. J Heart Lung Transplant 2007; 26:453-457
10. Zuppa AF, Nicolson SC, Adamson PC, et al: Population pharmacokinetics of milrinone in neonates with hypoplastic left heart syndrome undergoing stage I reconstruction. Anesth Analg 2006; 102:1062-1069
11. Hoffman TM, Wernovsky G, Atz AM, et al: Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003; 107: 996-1002
12. Turanlahti M, Boldt T, Palkama T, et al: Pharmacokinetics of levosimendan in pediat-ric patients evaluated for cardiac surgery. Pediatr Crit Care Med 2004; 5:457-462
13. Kolseth SM, Nordhaug DO, Stenseth R, et al: Prophylactic treatment with levosimendan: A retrospective matched-control study of patients with reduced left ventricular function. Eur J Cardiothorac Surg 2009; 36:1024-1030
14. Dies F: Intermittent dobutamine in ambulatory patients with chronic cardiac failure. Br J Clin Pract 1986; 45:37-40
15. Erlemeier HH, Kupper W, Bleifeld W: Intermittent infusion of dobutamine in the therapy of severe congestive heart failure-Long term effects and lack of tolerance. Cardio-vasc Drugs Ther 1992; 6:391-398
16. Oliva F, Latini R, Politi A, et al: Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial. Am Heart J 1999; 138:247-253
17. Cesario D, Clark J, Maisel A: Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: A preliminary study. Am Heart J 1998; 135: 121-129
18. Egan JR, Clarke AJ, Williams S, et al: Levo-simendan for low cardiac output: A pediatric experience. J Intensive Care Med 2006; 21: 183-187